TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
GUTS

Fractyl Health, Inc.

Healthcare · Biotechnology

0.4699$ -3.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement GUTS
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – 100.0% 100.0% –
– – – – 64.2% 53.8% –
– – – – 35.8% 46.2% –
– – – – 31,698.3% 75,775.3% –
– – – – 10,700.8% 24,841.9% –
– – – – 42,399.2% 100,617.2% –
– – – – -42,363.3% -100,571.0% –
– – – – -64,242.5% -73,864.5% –
– – – – -64,242.5% -73,864.5% –
– – – – -42,125.0% -73,136.6% –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?